Skip to main content

Table 1 Summary of clinical characteristics for the 15 individuals described in this study

From: Proteomic characterization of high-density lipoprotein particles in patients with non-alcoholic fatty liver disease

Characteristic

Control

N = 5

SS

N = 5

NASH

N = 5

p

Age (year)

49.8 (5.8)

49.2 (2.4)

51.2 (3.9)

0.72

BMI (kg/m2)

50.18 (7.2)

49.88 (6.1)

48.48 (4.7)

0.99

ALT U/L

15.4 (4.21)

25.2 (17.51)

25.4 (18.17)

0.37

Glucose (mg/dl)

98.6 (16.6)

144.2 (72.8)

118.8 (28.3)

0.13

Insulin (mu/ml)

20.06 (6.24)

18.81 (17.55)

28.06 (14.75)

0.73

HOMA

4.91 (1.81)

7.106 (10.01)

8.88 (6.24)

0.72

TChol (mg/dl)

160.8 (23.28)

157 (32.09)

188.25 (49.92)

0.69

TG (mg/dl)

90 (23.18)

173.6 (98.45)

191.75 (82.61)

0.18

HDL (mg/dl)

50.4 (6.06)

39.2 (15.51)

43.25 (6.94)

0.12

LDL (mg/dl)

92.4 (29.19)

93 (25.41)

106.75 (38.74)

0.91

LDL Med (nm)

25.98 (0.66)

26.69 (0.51)

26.19 (0.66)

0.07

HDL Med (nm)

8.54 (0.14)

8.74 (0.15)

8.49 (0.11)

0.02

  1. Values presented are mean (SD). Median LDL sizes were not found to be significantly different in subjects diagnosed with SS or NASH. However, median HDL size was found to be significant between the three groups. p value represents difference in mean values between the three conditions